Yang YC - Search Results

1

Intra-peritoneal hyperthermia combining α-galactosylceramide in the treatment of ovarian cancer.

Wu CC, Chuang YT, Hsu YT, Huang JT, Wu TC, Hung CF, Yang YC, Chang CL. Wu CC, et al. Among authors: yang yc. PLoS One. 2013 Jul 23;8(7):e69336. doi: 10.1371/journal.pone.0069336. Print 2013. PLoS One. 2013. PMID: 23935988 Free PMC article.

2

Nanoparticle-induced intraperitoneal hyperthermia and targeted photoablation in treating ovarian cancer.

Wu CC, Yang YC, Hsu YT, Wu TC, Hung CF, Huang JT, Chang CL. Wu CC, et al. Among authors: yang yc. Oncotarget. 2015 Sep 29;6(29):26861-75. doi: 10.18632/oncotarget.4766. Oncotarget. 2015. PMID: 26318039 Free PMC article.

3

Silencing of astrin induces the p53-dependent apoptosis by suppression of HPV18 E6 expression and sensitizes cells to paclitaxel treatment in HeLa cells.

Yang YC, Hsu YT, Wu CC, Chen HT, Chang MS. Yang YC, et al. Biochem Biophys Res Commun. 2006 May 5;343(2):428-34. doi: 10.1016/j.bbrc.2006.02.166. Epub 2006 Mar 9. Biochem Biophys Res Commun. 2006. PMID: 16546135

4

Immune mechanism of the antitumor effects generated by bortezomib.

Chang CL, Hsu YT, Wu CC, Yang YC, Wang C, Wu TC, Hung CF. Chang CL, et al. Among authors: yang yc. J Immunol. 2012 Sep 15;189(6):3209-20. doi: 10.4049/jimmunol.1103826. Epub 2012 Aug 15. J Immunol. 2012. PMID: 22896634

5

Dose-dense chemotherapy improves mechanisms of antitumor immune response.

Chang CL, Hsu YT, Wu CC, Lai YZ, Wang C, Yang YC, Wu TC, Hung CF. Chang CL, et al. Among authors: yang yc. Cancer Res. 2013 Jan 1;73(1):119-27. doi: 10.1158/0008-5472.CAN-12-2225. Epub 2012 Oct 29. Cancer Res. 2013. PMID: 23108141 Free PMC article. Clinical Trial.

6

Enhanced anti-tumor therapeutic efficacy of DNA vaccine by fusing the E7 gene to BAFF in treating human papillomavirus-associated cancer.

Wu CC, Wu FC, Hsu YT, Hsiao YC, Yang YC, Chang CA, Chang CL. Wu CC, et al. Among authors: yang yc. Oncotarget. 2017 May 16;8(20):33024-33036. doi: 10.18632/oncotarget.16032. Oncotarget. 2017. PMID: 28423693 Free PMC article.

7

Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.

Yang YC, Wu CC, Chen CP, Chang CL, Wang KL. Yang YC, et al. Gynecol Oncol. 2005 Nov;99(2):287-93. doi: 10.1016/j.ygyno.2005.06.018. Epub 2005 Jul 26. Gynecol Oncol. 2005. PMID: 16051341 Clinical Trial.

8

Possible surrogate marker for an effective dose-dense chemotherapy in treating ovarian cancer.

Huang CY, Yang YC, Wang KL, Chen TC, Chen JR, Weng CS, Chien HJ, Chang CL. Huang CY, et al. Among authors: yang yc. Taiwan J Obstet Gynecol. 2016 Jun;55(3):405-9. doi: 10.1016/j.tjog.2016.04.017. Taiwan J Obstet Gynecol. 2016. PMID: 27343324 Free article.

9

Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.

Huang CY, Yang YC, Chen TC, Chen JR, Chen YJ, Wu MH, Jan YT, Chang CL, Lee J. Huang CY, et al. Among authors: yang yc. J Cachexia Sarcopenia Muscle. 2020 Apr;11(2):534-546. doi: 10.1002/jcsm.12524. Epub 2020 Jan 30. J Cachexia Sarcopenia Muscle. 2020. PMID: 31999069 Free PMC article.

10

Bilateral calcified ovarian fibromas in a patient with Sotos syndrome.

Chen CP, Yang YC, Lin SP, Wang W, Chang CL, Chang KM. Chen CP, et al. Among authors: yang yc. Fertil Steril. 2002 Jun;77(6):1285-7. doi: 10.1016/s0015-0282(02)03118-7. Fertil Steril. 2002. PMID: 12057743 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,435 results

Search Page